Advances in Antibody-Based Therapeutics for Cerebral Ischemia

Advances in Antibody-Based Therapeutics for Cerebral Ischemia

Cerebral ischemia is an acute disorder characterized by an abrupt reduction in blood flow that results in immediate deprivation of both glucose and oxygen. The main types of cerebral ischemia are ischemic and hemorrhagic stroke. When a stroke occurs, several signaling pathways are activated, compris...

Full description

Bibliographic Details
Main Authors:	Jui-Ming Sun, Ting-Lin Yen, Jing-Shiun Jan, Pharaoh Fellow Mwale, Ruei-Dun Teng, Rajeev Taliyan, Cheng-Ta Hsieh, Chih-Hao Yang
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Pharmaceutics
Subjects:	antibody cerebral ischemia ischemic hemorrhagic blood brain barrier
Online Access:	https://www.mdpi.com/1999-4923/15/1/145

Similar Items

Angiopoietin-1 is associated with cerebral vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage
by: Pfausler Bettina, et al.
Published: (2011-05-01)

New concepts in cerebral ischemia /
by: Lin, Rick C. S., 1945-
Published: (2001)

The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury
by: Xiaolu Liu, et al.
Published: (2019-12-01)

The Role of Thromboinflammation in Delayed Cerebral Ischemia after Subarachnoid Hemorrhage
by: Devin W. McBride, et al.
Published: (2017-10-01)

Therapeutic strategies in cerebral ischemia /
by: Liebeskind, David S.
Published: (2011)

Effect of remote ischemic preconditioning on cerebral vasospasm and biomarkers of cerebral ischemia in aneurysmal subarachnoid hemorrhage (ERVAS): A protocol for a randomized, controlled pilot trial
by: R P Sangeetha, et al.
Published: (2019-01-01)

Delayed cerebral ischemia and therapeutic approaches after subarachnoid hemorrhage
by: Fettah Eren, et al.
Published: (2022-08-01)

Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review
by: William S. Dodd, et al.
Published: (2021-08-01)

The Role of Consecutive Plasma Copeptin Levels in the Screening of Delayed Cerebral Ischemia in Poor-Grade Subarachnoid Hemorrhage
by: Jong Kook Rhim, et al.
Published: (2021-03-01)

Monitoring of Delayed Cerebral Ischemia in Patients with Subarachnoid Hemorrhage via Near-Infrared Spectroscopy
by: Jeong Jin Park, et al.
Published: (2020-05-01)

The Role of the Glycocalyx in the Pathophysiology of Subarachnoid Hemorrhage-Induced Delayed Cerebral Ischemia
by: Hanna Schenck, et al.
Published: (2021-09-01)

Admission Homocysteine as a Potential Predictor for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
by: Tiesong Zhang, et al.
Published: (2022-02-01)

Monitoring in neurointensive care – The challenge to detect delayed cerebral ischemia in high grade aneurysmal SAH
by: Asita S Sarrafzadeh, et al.
Published: (2014-07-01)

Dynamic Change in Mean Platelet Volume and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
by: Liuwei Chen, et al.
Published: (2020-11-01)

Pathophysiology, Management, and Therapeutics in Subarachnoid Hemorrhage and Delayed Cerebral Ischemia: An Overview
by: Henry W. Sanicola, et al.
Published: (2023-09-01)

Current progress in searching for clinically useful biomarkers of blood–brain barrier damage following cerebral ischemia
by: Weili Li, et al.
Published: (2018-01-01)

Characterization of the TCR β Chain CDR3 Repertoire in Subarachnoid Hemorrhage Patients with Delayed Cerebral Ischemia
by: Bong Jun Kim, et al.
Published: (2020-04-01)

Multimodality Monitoring for Delayed Cerebral Ischemia in Subarachnoid Hemorrhage: A Mini Review
by: Collin M. Labak, et al.
Published: (2022-04-01)

Devastating delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
by: Inez Koopman, et al.
Published: (2022-10-01)

Effect of remote ischemic preconditioning on cerebral vasospasm, biomarkers of cerebral ischemia, and functional outcomes in aneurysmal subarachnoid hemorrhage (ERVAS): A randomized controlled pilot trial
by: R P Sangeetha, et al.
Published: (2021-01-01)

Research hotspots and frontiers of preconditioning in cerebral ischemia: A bibliometric analysis
by: Long Zhang, et al.
Published: (2024-02-01)

The association of neutrophil-to-lymphocyte ratio and delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage: possible involvement of cerebral blood perfusion
by: Wu Y, et al.
Published: (2019-04-01)

The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
by: Nicolas Bruder, et al.
Published: (2022-12-01)

Role of Carbonic Anhydrase in Cerebral Ischemia and Carbonic Anhydrase Inhibitors as Putative Protective Agents
by: Irene Bulli, et al.
Published: (2021-05-01)

Hypoperfusion assessed by pressure reactivity index is associated with delayed cerebral ischemia after subarachnoid hemorrhage: an observational study
by: Bin Bin Fan, et al.
Published: (2021-03-01)

Mechanisms Underlying Curcumin-Induced Neuroprotection in Cerebral Ischemia
by: Feng Fan, et al.
Published: (2022-04-01)

Propofol Affords No Protection against Delayed Cerebral Ischemia in a Mouse Model of Subarachnoid Hemorrhage
by: Meizi Liu, et al.
Published: (2023-09-01)

Screening Computed Tomography Angiography to Identify Patients at Low Risk for Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage
by: Andrew M. Nguyen, et al.
Published: (2021-11-01)

MALAT1 knockdown alleviates the pyroptosis of microglias in diabetic cerebral ischemia via regulating STAT1 mediated NLRP3 transcription
by: Nan Zhao, et al.
Published: (2023-04-01)

Systematic review of melatonin in cerebral ischemia-reperfusion injury: critical role and therapeutic opportunities
by: Chenguang Zhang, et al.
Published: (2024-02-01)

Progress of relationship between cerebral microbleeds and intracranial hemorrhage secondary to cerebral ischemic events
by: Jie ZHUO
Published: (2019-09-01)

Slow recruitment in the HIMALAIA study: lessons for future clinical trials in patients with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage based on feasibility data
by: Celine S. Gathier, et al.
Published: (2022-08-01)

Sirt1 in cerebral ischemia
by: Kevin B Koronowski, et al.
Published: (2015-01-01)

Increased Systemic Immune-Inflammation Index Is Associated With Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage Patients
by: Liuwei Chen, et al.
Published: (2021-10-01)

Neuroprotective Effects of Pregabalin on Cerebral Ischemia and Reperfusion
by: Sanem Aşçı, et al.
Published: (2016-04-01)

HISTOLOGICAL VIOLATIONS IN THE RAT HIPPOCAMPUS AND PARIETAL CORTEX IN TOTAL CEREBRAL ISCHEMIA
by: Bon E. I., et al.
Published: (2020-12-01)

Enriched Environment Attenuates Pyroptosis to Improve Functional Recovery After Cerebral Ischemia/Reperfusion Injury
by: Jingying Liu, et al.
Published: (2021-09-01)

Changes in the amino acid pool of cerebral hemispheres in rats with total cerebral ischemia
by: Bon, Elizaveta I., et al.
Published: (2023-12-01)

Sufentanil alleviates cerebral ischemia-reperfusion injury by inhibiting inflammation and protecting the blood-brain barrier in rats
by: Zhen Wang, et al.
Published: (2022-01-01)

Elevated concentrations of macrophage migration inhibitory factor in serum and cerebral microdialysate are associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
by: Felix Neumaier, et al.
Published: (2023-01-01)